what class of drug is semaglutide Lesson: Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment Type 2 Diabetes Mix-it-yourself Wegovy? Some try risky

Weight loss follows a similar trajectory, with most reduction occurring in the first 612 months of therapy

To view or add a comment, sign in Eli Lilly and Company Reports Additional Positive Phase 3 Results for Retatrutide Across Multiple Obesity-Related Conditions On June 6, Eli Lilly and Company announced additional positive pivotal Phase 3 results for its investigational GLP-1/GIP/GCG triple receptor agonist, #Retatrutide

GLP-1 RAs have shown promising effects in the treatment of HS, but limitations exist in the current literature

However, because of its unique mechanism of action, further research is needed to see what other side effects are possible.

What are the consequences of inadequate protein